Suppr超能文献

基于“肾虚血瘀”理论的中医药治疗免疫性不孕的疗效与安全性:系统评价与Meta分析

Efficacy and Safety of Traditional Chinese Medicine in the Treatment of Immune Infertility Based on the Theory of "Kidney Deficiency and Blood Stasis": A Systematic Review and Meta-Analysis.

作者信息

Bai Yi-Ling, Chen Yun-Hui, Jiang Cui, Qian Jun-Hui, Han Ling-Ling, Lu Hai-Zhen, Wang Hao-Zhong, Sun Yi-Rong

机构信息

College of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.

Hospital of Chengdu University of Traditional Chinese Medicine, No. 39 Shi-er-qiao Road, Chengdu, Sichuan 610072, China.

出版信息

Evid Based Complement Alternat Med. 2021 May 15;2021:9947348. doi: 10.1155/2021/9947348. eCollection 2021.

Abstract

OBJECTIVE

This study aims to evaluate the efficacy and safety of traditional Chinese medicine (TCM) therapy of tonifying kidney and activating blood circulation (TKABC) based on the theory of "kidney deficiency and blood stasis" for the treatment of immune infertility.

METHODS

Six electronic databases, including the Cochrane Library, PubMed, EMBASE, the China National Knowledge Infrastructure, Wanfang Data, and VIP information database, were searched from inception to January 2021 to identify eligible studies of randomized controlled trials (RCTs). The primary outcome measurements were the total effective rate and pregnancy rate, and the secondary outcome measurements included the negative conversion rate of serum antibodies and the incidence of adverse effects. The quantitative synthesis was performed using the Review Manager 5.3 software. The chi-square statistic and statistic were employed to investigate statistical heterogeneity. The fixed-effects model was used for a low heterogeneity (  < 50%), and the random-effects model was applied if heterogeneity was moderate (50% <   < 75%). Funnel plots were used to evaluate potential reporting bias when more than ten eligible studies were included.

RESULTS

Thirteen RCTs involving 1298 patients with immune infertility of kidney deficiency and blood stasis were included. Compared with conventional group, TCM TKABC therapy showed a significant improvement on the total effective rate (RR: 1.38; 95% CI: 1.30,1.47; and  = 0%), pregnancy rate (RR: 2.04; 95% CI: 1.73, 2.40; and  = 30%), negative conversion rates of AsAb (RR: 1.42; 95% CI: 1.12,1.79; and  = 62%), AEmAb rates (RR: 1.21; 95% CI: 1.04,1.41; and I = 0%), and AhCGAb with less adverse effects (RR: 0.24; 95% CI: 1.73, 2.40; and  = 55%). However, the negative conversion rate of AoAb and ACAb showed no significant statistical difference.

CONCLUSIONS

Our review suggests that TCM TKABC therapy based on the theory of kidney deficiency and blood stasis appears to be an effective and safe approach for patients with immune infertility. However, the methodological quality of included RCTs was unsatisfactory, and it is necessary to verify its effectiveness with more well-designed and high-quality multicenter RCTs.

摘要

目的

本研究旨在基于“肾虚血瘀”理论,评估补肾活血中药疗法治疗免疫性不孕的疗效和安全性。

方法

检索Cochrane图书馆、PubMed、EMBASE、中国知网、万方数据和维普资讯数据库6个电子数据库,检索时间从建库至2021年1月,以确定符合条件的随机对照试验(RCT)研究。主要结局指标为总有效率和妊娠率,次要结局指标包括血清抗体转阴率和不良反应发生率。采用Review Manager 5.3软件进行定量合成。采用卡方检验和I²统计量来研究统计异质性。异质性低(I²<50%)时采用固定效应模型,异质性中等(50%<I²<75%)时采用随机效应模型。当纳入超过10项符合条件的研究时,采用漏斗图评估潜在的报告偏倚。

结果

纳入13项RCT,共1298例肾虚血瘀型免疫性不孕患者。与传统治疗组相比,补肾活血中药疗法在总有效率(RR:1.38;95%CI:1.30,1.47;I²=0%)、妊娠率(RR:2.04;95%CI:1.73,2.40;I²=30%)、抗精子抗体(AsAb)转阴率(RR:1.42;95%CI:1.12,1.79;I²=62%)、抗子宫内膜抗体(AEmAb)转阴率(RR:1.21;95%CI:1.04,1.41;I²=0%)、抗绒毛膜促性腺激素抗体(AhCGAb)转阴率方面有显著改善,且不良反应较少(RR:0.24;95%CI:1.73,2.40;I²=55%)。然而,抗卵巢抗体(AoAb)和抗心磷脂抗体(ACAb)转阴率差异无统计学意义。

结论

我们的综述表明,基于肾虚血瘀理论的补肾活血中药疗法对免疫性不孕患者似乎是一种有效且安全的方法。然而,纳入的RCT研究方法学质量不尽人意,有必要通过更多设计良好、高质量的多中心RCT来验证其有效性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验